Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Takeda Pharmaceutical Co Ltd ( - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
TAK
New York
2834
https://www.takeda.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Takeda Pharmaceutical Co Ltd (
Down -5.9% in 4 Weeks, Here's Why Takeda Pharmaceutical Co. (TAK) Looks Ripe for a Turnaround
- Apr 26th, 2024 1:35 pm
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
- Apr 26th, 2024 12:30 pm
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
- Apr 26th, 2024 12:30 pm
All You Need to Know About Takeda Pharmaceutical Co. (TAK) Rating Upgrade to Strong Buy
- Apr 25th, 2024 4:00 pm
TAK or CTLT: Which Is the Better Value Stock Right Now?
- Apr 25th, 2024 3:40 pm
20 Fastest Growing Health Tech Companies in the World
- Apr 25th, 2024 3:34 pm
Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?
- Apr 25th, 2024 1:40 pm
New Strong Buy Stocks for April 25th
- Apr 25th, 2024 10:52 am
Best Value Stocks to Buy for April 25th
- Apr 25th, 2024 10:13 am
Best Income Stocks to Buy for April 25th
- Apr 25th, 2024 8:37 am
Takeda Pharmaceutical: A Long-Term Cash Cow
- Apr 23rd, 2024 2:00 pm
Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1065845 in Adults with Major Depressive Disorder
- Apr 23rd, 2024 11:00 am
Pharmas form joint venture to jumpstart Japanese drug research
- Apr 22nd, 2024 9:50 am
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
- Apr 22nd, 2024 8:10 am
MasterCraft Boat, SentinelOne, and More Stocks See Action From Activist Investors
- Apr 19th, 2024 7:03 pm
U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
- Apr 18th, 2024 11:00 pm
Takeda Announces New U.S. Corporate Social Responsibility Program Partners to Build Equity through STEM Education and Access to Nutritional Food
- Apr 8th, 2024 12:00 pm
ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors
- Apr 5th, 2024 10:30 pm
Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE
- Mar 27th, 2024 12:53 pm
Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting
- Mar 26th, 2024 11:07 pm
Scroll